Researcher Steven Grant appointed to three major committees
VCU Massey Cancer Center researcher Steven Grant, M.D., was recently honored with appointments to three influential committees: one for the Alliance for Clinical Trials in Oncology (ACTION) and two for the American Association for Cancer Research (AACR). Shirley Carter Olsson and Sture Gordon Olsson Chair in Oncology Research, associate director for translational research and program co-leader of Developmental Therapeutics, Grant was selected for these positions based on his proven track record in translational research and expertise in biochemistry and pharmacology, respectively.
As a member of ACTION's Experimental Therapeutics Committee, Grant will advise the group about novel therapeutic anti-cancer strategies, and he will develop and approve group protocols to facilitate the advancement of cutting-edge cancer treatments. ACTION is a large cooperative of NCI-sponsored groups, including the American College of Surgeons Oncology Group, the North Central Cancer Treatment Group and the Cancer and Leukemia Group B. ACTION works to reduce the impact of cancer by conducting multidisciplinary cancer prevention, control and treatment trials; broadening the understanding of the biological basis of cancer and its treatments; and providing scientific and operational infrastructure for innovative clinical and translational research.
Grant's roles with AACR will help facilitate the organization's 2012 annual meeting, an event expected to host more than 7,000 scientists March 31 to April 4, 2012 in Chicago, IL. As a member of the AACR's Education Committee, Grant will recommend the topics and chairpersons for the Educational Sessions and Methods Workshops portion of the meeting. He will also chair the Educational Session on the PI3K/AKT/mTOR pathway in cancer therapy. Additionally, Grant will chair the Drug Discovery Subcommittee of the Experimental and Molecular Therapeutics Section of the 2012 Program Committee. In this position he will take the lead in evaluating hundreds of abstracts for presentation at the meeting, and will help plan program presentations.
"These appointments underscore Dr. Grant's reputation for translating promising laboratory research into exciting new cancer treatments," says Director of VCU Massey Cancer Center Gordon D. Ginder, M.D. "He is an asset to our team of dedicated researchers and clinicians, and he will also serve these committees well."